Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
MOVEMENT DISORDERS Dayna Ryan, PT, DPT Winter 2012 Summary • Typically involve dysfunction to the basal ganglia and cerebellum • Both influences movement via the thalamus to motor areas of the cerebral cortex • UMNL or LMNL? • It’s a Upper Lesion (chapter 10 Lundy-E) Basal Ganglia The Role of the BG in Movement Motor Thalamus Motor Cortex Corticospinal tracts LMNs Voluntary muscles BG Postural and girdle muscles LMNs Pedunculopontine nucleus Reticulospinal & vestibulospinal tracts Basal Ganglia Circuitry • DIRECT PATHWAY • Striatum -> internal globus pallidus & substantia nigra parts retiulata • These then project to the thalamus VA / VL • Movement results when thalamic cells are released from tonic inhibition • INCREASES excitatory thalamic drive to SMA • TURNS UP motor activity Normal Basal Ganglia Circuitry • DIRECT PATHWAY • Straitum -> internal • • • • globus pallidus and substantia nigra parts retiulata These then project to the thalamus (inhibitory signal) Movement results when thalamic cells released from tonic inhibition INCREASES excitatory thalamic drive to SMA TURNS UP motor activity Normal Basal Ganglia Circuitry • INDIRECT PATHWAY • Striatum -> external globus pallidus -> subthalamic nucleus • DECREASES excitatory thalamic drive to SMA • TURNS DOWN motor activity • Direct pathway TURNS UP motor activity • Indirect pathway TURNS DOWN motor activity • Direct and indirect pathways counterbalance each other to maintain normal movement function. • Basal Ganglia controls the motor commands Dopaminergic Modulation Cholinergic (ACh) Modulation • Excitatory effect on D1 receptors in direct pathway • Inhibitory effect on D2 receptors in indirect pathway • TURNS UP motor activity • Cholinergic (ACh) interneuron: Inhibits the direct pathway and Excites the indirect pathway • TURNS DOWN motor activity Parkinson’s Disease • Parkinsonism: a group of rare diseases or syndromes, with signs and symptoms similar to Parkinson’s disease (PD) • PD: the most common form of parkinsonism; a.k.a. primary parkinsonism or idiopathic PD • At least 500,000 people currently have Parkinson's disease, ~ 50,000 new cases annually • Average age of onset = 60 years; Incidence increases incrementally after age 50 • ~ 5-10 % diagnosed before age 50 ("early-onset“) Parkinson’s Disease: Pathology • Severe loss of substantia nigra (SN) dopaminergic neurons • Most PD patients have lost 60-80% or more of the dopamine- producing cells in the substantia nigra by the time symptoms appear Parkinson’s Disease: Histology • Histology hallmark in PD is Lewy bodies (abnormal aggregates, clumps composed principally of the protein alphasynuclein) • Lewy bodies form primarily in the substantia nigra and brainstem, but can also be elsewhere in the brain • Researchers do not yet know why Lewy bodies form or what role they play in development of the disease. They may interfere with transmission of nerve signals. Abnormal Basal Ganglia Circuitry in PD • Since dopamine cells are lost in PD… • Direct pathway activity ↓ = LESS MOTOR ACTIVITY • Indirect pathway activity ↑ = LESS MOTOR ACTIVITY Causes of PD • Genetic • Environmental • Toxins, e.g. MPTP (in heroin), DDT (in pesticides) • Viruses, e.g. 1918 influenza, herpes virus infection • Interaction of Genetic & Environmental Factors • Even in familial cases, exposure to toxins or other environmental factors may influence when symptoms of the disease appear or how the disease progresses • Mitochondrial Dysfunction • Oxidative Stress • Cerebral Inflammation Parkinson’s Disease Symptoms • Cardinal Symptoms: • Resting Tremor • “pill rolling”, back-and- forth motion • Rate: 4-6 Hz • Bradykinesia • Slowing down; less consistent and slow force production • Loss of spontaneous and automatic movements • Rigidity • Cogwheel • Lead-pipe (when rigidity becomes severe) • Postural Instability • More likely to use hip instead of ankle strategies, due to inappropriate scaling of sensory feedback • Hypometric anticipatory postural adjustments Parkinson’s Disease: Bradykinesia • Slower and less consistent force production Stelmach, GE 1989 Parkinson’s Disease Symptoms • Other symptoms: • Difficulty with swallowing and chewing • Speech impairments: Speak too softly, monotone, hesitant, slurred, repeating words • “Masked” face/Expression-less • Depressed, irritable, other emotional changes • Fatigued-more muscle activity • Sleep problems-when resting they shake • Urinary problems or constipation • Skin problems: very oily, very dry, excessive sweating • Decreased strength in muscles of respiration • Dementia or other cognitive problems • Orthostatic hypotension Parkinson’s Disease: Postural Changes • Kyphotic posture with forward-flexed trunk • Forward head • Crouched legs • Mask-like face (expression-less) Parkinson’s Disease: Gait • Difficulty INITIATING gait • Freezing gait • Patient will report that it feels like their feet are stuck on the ground/heavy and they cannot move • Festinating gait • Steps too small • Causes COM to get in front of BOS (upper body going faster than lower body) • Can’t always catch themselves so typically fall forward • Decreased foot clearance • Decreased or no trunk rotation • No arm swing Parkinsons’ Disease: Abnormal Postural Control Strategies • Abnormal combination of ankle and hip strategies concurrently exhibited Parkinson’s Disease: Micrographia • Handwriting is slow and looks cramped or small. Parkinson’s Disease Progression • PD is not by itself a fatal disease but it does get worse with time • PD generally does not affect life expectancy • In the later stages of the disease, PD-related complications can lead to death, such as choking, pneumonia, and falls • Progression of symptoms may take 20 years or more (In some, PD progresses more quickly) Parkinson’s Disease Progression: Hoehn & Yahr Staging • Stage One • Unilateral, one side of the body • Symptoms mild, inconvenient but not disabling • Usually presents with tremor of one limb • Friends noticing change in posture, gait, facial expression • Stage Two • Bilateral, both sides of the body • Minimal disability • Posture and gait affected • Stage Three • Significant slowing of movement • Early impairment of equilibrium on gait or standing • Generalized dysfunction that is moderately severe • Stage Four • Severe symptoms • Can still walk to a limited extent • Rigidity and bradykinesia • No longer able to live alone • Tremor may be less than earlier stages • Stage five • Cachectic stage • Invalidism complete • Cannot stand or walk • Requires constant nursing care Parkinsons Disease: UPDRS (United Parkinson Disease Rating Scale) • Updated version in 2008 • Sections include: • Mentation, Behavior, and Mood • ADL • Motor function • 199 points total • Higher score indicate increasing disability UPDRS Example Items Parkinson’s Disease Diagnosis • No blood or laboratory tests • Medical history & neurological exam • Difficult to diagnose accurately • early signs and symptoms may be dismissed as the effects of normal aging • Clinical signs and symptoms • must have 2 or more cardinal signs • Positive response to dopamine agonist medication • Unified Parkinson's Disease Rating Scale (UPDRS) • CT or MRI in PD usually appear normal but may be needed to rule out other diseases Parkinson’s Disease Medications • Levodopa (L-dopa) —A dopamine precursor that crosses the blood-brain barrier and then converts to dopamine —Side effects increase with continued usage, including —Nausea, hypertension (due to activation of peripheral dopamine receptors) —Dyskinesias (involuntary movements, e.g. twitching, twisting) —“tolerance” develops with continued usage —Period of effectiveness after each does begins to shorten —Larger doses may be needed to be effective —“On-Off” effects • Sinemet (a combination of Carbidopa and Levodopa) —Does not cross the blood brain barrier but prevents peripheral conversion of levodopa to dopamine and thereby reduces the unwanted peripheral side-effects of levodopa Parkinson’s Disease Medications • Dopamine agonists —Mimics the effects of dopamine in the brain —Given alone or in conjunction with L-dopa —Can lengthen the duration of response to L-dopa in patients that are developing “tolerance” and “on-off” effects —Apomorphone, bromocriptin, pramipexole, ropinirole • Anticholinergics • Decrease the activity of ACh (Striatum has ACh interneurons, which oppose the effect of D1 and D2 receptors in the striatum) • Reduce tremors and muscle rigidity • Trihexyphenidl, benztropine Parkinson’s Disease Medications • MAO-B inhibitors —Inhibit the enzyme monoamine oxidase B (MAO-B), which breaks down dopamine in the brain —Delay the need for L-dopa by up to a year or more —Azilect (Rasagiline) • COMT inhibitors —Inhibit the enzyme Catechol-O-Methyltransferase (COMT), which breaks down dopamine —Decrease the duration of “off” periods; make it possible to reduce Ldopa dosage —Entacapone, tolcapone • Other Medications for non-PD symptoms Parkinson’s Disease: Surgery • Used if medications no longer effective • Ablation — Selectively destroying specific cells that contribute to the symptoms — Pallidotomy (reduce tremor, rigidity, and bradykinesia) — Thalamotomy (reduce tremor) • Deep brain stimulation (DBS) —Electrodes implanted in thalamus, subthalamic nucleus, and globus pallidus —Electrodes connected to a pulse generator —The pulse generator and electrodes painless stimulate the brain —Blocks electrical signals from targeted areas —Reduces the need for medications • Embryonic stem cell transplant Recent Research Findings: Implications for Interventions • Paradoxical Kinesia (“motion”) • A deficit to execute movements can be overcome in the presence of external sensory cues (e.g. visual, auditory, proprioception) • Rationale: distinct contribution of the corticostriatal (implicit) and cortico-cerebellar (explicit) systems to motor learning and control • Provide external sensory cues to bypass the defected cortico-striatal system Treatment for Freezing Gait in PD • Visual cue on floor within one • LaserCane™ projects step length will stimulate a step a bright red line across your path • Can add hand triggered laser light to a walker Videos for PD • Before and after L-dopa • http://www.youtube.com/watch?v=sf1N0Zf5IqA&feature=related • Michael J. Fox • http://www.youtube.com/watch?v=ECkPVTZlfP8 • What you will likely see • http://www.youtube.com/watch?v=29zHputMEQA&feature=related • http://www.youtube.com/watch?v=oUDDRUtJcgM&feature=related Huntington’s Disease (HD) • Huntington’s chorea • Involuntary choreoform movements • Rapid, involuntary, purposeless jerks of irregular and variable location on the body • Hereditary (autosomal dominant) • 50% inheritance rate in offspring • No treatment to stop or reverse the progression • Striatum affected. Huntington’s Disease (HD) • Pathology • Primarily involved neuronal deaths in the Striatum (= Caudate & Putamen) • Enlarged ventricles, degenerative cortex & cerebellum • Abnormal Basal Ganglia Circuitry • Reduction of neurotransmitter, GABA, ACh, metenkephalin due to loss of neurons in the striatum • Causes relatively higher concentration of dopamine and norepinepherine excessive excitation of thalamocortical pathways choreoform movements Huntington’s Disease • Choreiform movements due to: • Direct pathway activity ↑ = MOTOR ACTIVITY ↑ • Indirect pathway activity ↓ = MOTOR ACTIVITY ↑ http://www.youtube.com/watch?v=kINXIjs_V3M&fe ature=related http://www.youtube.com/watch?v=OveGZdZ_sVs Abnormal Basal Ganglia Circuitry in HD Huntington’s Chorea Primary Characteristics • Choreic Movements • Brief • Purposeless • Involuntary • Random • Personality and Psychiatric Disturbances • Irritable, apathy, depression • Explosive behaviors • Dementia • Decreased intellect • Decreased memory, attention Other Signs and Symptoms • Dysarthria (speaking) • Dysphagia (swallowing) • Cachexia (muscle wasting) • Sleep disorders • Urinary incontinence • Depression • Apraxia • May become severe • Ideomotor form Huntington’s Disease: Motor and Sensory Signs Motor • DTRs = normal • Strength = normal early in disease • Tone • Normal initially • Later become rigid • Apraxia - ideomotor • Cannot sustain long muscle contractions Sensory • Abnormal eye movement • Impaired saccade • Impaired smooth pursuit • Impaired gaze fixation • Visuospatial deficits • E.g. may not be able to see a figure embedded in a picture HD Movement Patterns • Undershoot targets • Decreased velocity of movement • Latency in initiation (can develop freezing gait) • Wide-based staggering gait • Dysdiadochokinesia (pronate/supinate) • Macrographia Writing samples from Jan 21 and Nov 13 of same year HD Disease Progression • Onset • Juvenile: before age 20 • Adult: after age 50 • Juvenile – more severe course • Suicide • 6% of deaths • 25% attempt suicide • As disease progresses • More dystonic contractions • May develop rigidity and bradykinesia • Less choreoform movement (because more rigid) • Death • Typically from intercurrent infection (usually in lungs) • 15-20 years after onset Huntington’s Disease: Diagnosis and Treatment Diagnosis Medical Treatment • DNA testing • Anticonvulsants • MRI to show atrophy of • Antipsychotic agents striatum in later stages • Surgery to remove globus pallidus • Deep brain stimulation Dystonia • Etiology • Unknown, idiopathic in most cases • Defected DYT1 gene in early onset dystonia • Secondary to some other neurologic disorders • Pathogenesis • Lesions at Caudate, Putamen and Globus pallidus • Overactive direct pathway within the basal ganglia circuitry increases motor activity Characteristics of Dystonic Movements • • • • • • • Definition = abnormal tonicity of muscle with simultaneous contraction of agonist and antagonist Involuntary muscle spasms force affected parts of the body into contorted or twisted postures Rapid or slow; Rhythmic or un-patterned Duration varies: < 1 s, a few sec or min, hours or longer May be increased with stress, during purposeful movements, task-specific (Sx only present during specific tasks, e.g. writing, playing instruments) Decrease after relaxation and disappear during sleep Often painful condition Dystonia • Focal and generalized forms • Focal • Pharyngeal • Distorted speech; affect vocal cords • Cervical dystonia • Most common • Hypertrophy of SCM muscle • Rotation of neck with lateral flexion and flex/ext of neck; typically painful • Is NOT torticollis (a musculoskeletal disorder with muscle fibrosis) • Writer’s cramp (task-specific focal dystonia) • Spasm affecting certain muscles of the hand and/or fingers • Musician’s cramp (task-specific focal dystonia) • Blepharospasm = uncontrollable blinking • Can be considered legally blind Dystonia: Disease Progression • Onset • Generalized ~ 8 y. o. • Focal 30-50 y. o. • Progression • Dystonia is not fatal, but is chronic and often painful and debilitating • Generalized begins in legs and progresses to rest of body • Focal dystonia progresses for about 5 years then plateau • Spontaneous recovery in 30% of cases Dystonia • Medications • BOTOX • Effective for 3-4 months • For focal dystonia • Common medications for Generalized Dystonia • Baclofen (treats spasticity) • Artane • Sinemet (parkinson) • Klonopin • Surgeries • Deep brain stimulation of the Globus pallidus • Rhizotomy • Resection of anterior (motor) cervical spinal nerve roots • Treatment in research phase • RNA interference (RNAi) therapy • Suppress the expression of mutated DYT1 gene to prevent further involvement with cell replication Videos on Dystonia • Generalized Dystonia • http://www.youtube.com/watch?v=b1yc6YnvrMs&feature=related • Focal Dystonia • http://www.youtube.com/watch?v=D8_98t74PnQ&feature=related • http://www.youtube.com/watch?v=UzI_4IOw3_8&feature=related Friedreich’s Ataxia • Lesion: • Cerebellum • Dorsal root ganglia • Dorsal columns • Spinocerebellar tracts • Some corticospinal tract involvement • Etiology: Hereditary (Autosomal recessive) • Onset • Between 5 to 15 y. o. (some later) • 25% of offspring have FA • Course (highly variable) • Generally lose ability to walk and confined to WC within 10-20 years after onset • Prognosis • Some survive into their 60’s & 70’s if no heart attack Friedreich’s Ataxia: Signs and Symptoms • Ataxia • Most common Sx • Gait ataxia is usually the first • • • • • • Sx • Ataxia gradually worsens and spreads to the arms and the trunk Clumsiness and intention tremor Muscle weakness and wasting Loss of sensation in extremities + Babinski (esp. if corticospinal tract involved) Decreased DTRs Tone is normal at rest • May get flexor spasms • Nystagmus (20% of cases) • Impaired smooth pursuit • Heart disease • various forms (e.g. cardiomyopathy, dysrhythmia) • 60% of population • Easily fatigued • Scoliosis • Dysarthria/tongue and oral motor issues Videos of FA • http://www.youtube.com/watch?v=CBlrp-Ok38E • FYI – very long video • http://www.youtube.com/watch?v=pfxPJVryhRE&feature=related Dyskinesia = a movement disorder that consists of decreased voluntary movements and increased involuntary movements • Tic • Chorea • Tardive Dyskinesia = involuntary movements of the tongue, lips, face, trunk, and extremities that occur in patients treated with long-term dopaminergic antagonist medications • http://www.youtube.com/watch?v=UbBpt9uCXqc&feature=related • http://www.youtube.com/watch?v=W_3bbpFjI68 • http://www.youtube.com/watch?v=R0EbgpyztCA&feature=fvwrel Review